Ensuring the precision, safety and cost effectiveness of cell and gene therapies are undoubtedly the biggest challenges faced by the industry to unlock the great potential of these cutting-edge evolving technologies.

Optimizing the manufacture and delivery of significant amounts of therapeutically potent cells, extend today’s frontiers in the field of cell therapy and regenerative medicine.

Choosing the right platforms, vectors, a comprehensive approach and the right partners will help you in the quest to deliver a better patient outcome avoiding possible complications.

Leaders in the pharma and biotech industry, health care sector and life science researchers will get insights about the latest advances in:

• Regenerative medicine
• Gene editing platforms
• Tackling the critical limitations in developing CRISPR therapeutics
• And the lessons learned during this journey

REGISTER HERE